Results 121 to 130 of about 9,925 (218)

Vascular defects of DYRK1A knockouts are ameliorated by modulating calcium signaling in zebrafish

open access: yesDisease Models & Mechanisms, 2019
DYRK1A is a major causative gene in Down syndrome (DS). Reduced incidence of solid tumors such as neuroblastoma in DS patients and increased vascular anomalies in DS fetuses suggest a potential role of DYRK1A in angiogenic processes, but in vivo evidence
Hyun-Ju Cho   +8 more
doaj   +1 more source

Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases [PDF]

open access: yes, 2014
Marine invertebrates produce a plethora of bioactive compounds, which serve as inspiration for marine biotechnology, particularly in drug discovery programs and biomaterials development.
Andrade, Paula B.   +3 more
core   +2 more sources

Evaluation of the Effects of Green Tea Extracts on Bone Homeostasis in the Ts65Dn Down Syndrome Mouse Model [PDF]

open access: yes, 2013
poster abstractDown Syndrome (DS) is a genetic disorder that affects ~1 in 700 live births, caused by trisomy of human chromosome 21 (Hsa21), and results in cognitive impairment, craniofacial abnormalities, low muscle tone, and skeletal deficiencies ...
Abeysekera, Irushi S.   +3 more
core  

Deciphering DYRK1A Signaling using Proteomics and Transcriptomics

open access: yesThe FASEB Journal, 2018
Trisomy 21 is the most common genetic manifestation of intellectual disability, with deleterious brain phenotypes thought to be caused by increased dosage of critical genes on chromosome 21, including the kinase DYRK1A. Additionally, individuals with Down syndrome are at an increased risk of developing Alzheimer's disease, immune dysfunction and ...
Zachary Poss   +5 more
openaire   +1 more source

Correction of cerebellar movement related deficits by normalizing Dyrk1a copy number in the Ts65Dn mouse model for Down syndrome [PDF]

open access: yes, 2016
poster abstractElucidation of the underlying mechanisms involved in brain related deficits of Down syndrome (DS) would be useful for consideration of therapeutic interventions.
Abeysekera, Irushi   +4 more
core  

Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway

open access: yesClinical and Experimental Hypertension
Pulmonary arterial hypertension (PAH) is characterized by progressive vascular remodeling caused by the excessive proliferation and survival of pulmonary artery smooth muscle cells (PASMCs).
Cong Lan   +5 more
doaj   +1 more source

DYRK1A-related intellectual disability syndrome

open access: yesČesko-slovenská pediatrie, 2022
Kateřina Slabá   +7 more
openaire   +1 more source

DYRK1A-mediated Hyperphosphorylation of Tau [PDF]

open access: yesJournal of Biological Chemistry, 2007
Soo-Ryoon Ryoo   +10 more
openaire   +1 more source

Effects of EGCG treatment on deficits in a radial-arm maze spatial pattern separation task in a Down syndrome mouse model [PDF]

open access: yes, 2015
poster abstractDown syndrome (DS) is caused by three copies of human chromosome 21 (Hsa 21) and results in a constellation of phenotypes that include intellectual disability.
Abeysekera, Irushi   +6 more
core  

EGCG Treatment on Ts65Dn Mice Suggests a Possible Correlation in Cognitive Development Deficit Reduction [PDF]

open access: yes, 2014
poster abstractDown syndrome (DS) is caused by trisomy of human chromosome 21 (Ts21), affecting 1 in 700 live births. Ts21 results in about 80 phenotypes of which intellectual disability (ID) is one of the most debilitating.
Abeysekera, Irushi S.   +2 more
core  

Home - About - Disclaimer - Privacy